Timothy R. Surgenor
Corporate Officer/Principal bei Red Sky Partners LLC
Profil
Timothy R.
Surgenor is currently a Partner at Red Sky Partners LLC since 2009.
He was previously the President & CEO of Trafalgar Ventures, Inc. and Cyberkinetics Neurotechnology Systems, Inc. from 2002 to 2009.
He was also an Independent Director at NeuroMetrix, Inc. from 2009 to 2020.
Additionally, he served as an Executive Vice President at Haemonetics Corp.
from 1999 to 2003 and was the President of Genzyme Tissue Repair from 1994 to 1999.
He holds an undergraduate degree from Williams College and an MBA from Harvard Business School.
Aktive Positionen von Timothy R. Surgenor
| Unternehmen | Position | Beginn |
|---|---|---|
| Red Sky Partners LLC | Corporate Officer/Principal | 19.02.2010 |
Ehemalige bekannte Positionen von Timothy R. Surgenor
| Unternehmen | Position | Ende |
|---|---|---|
| NEUROMETRIX, INC. | Direktor/Vorstandsmitglied | 28.04.2020 |
Cyberkinetics Neurotechnology Systems, Inc.
 Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Vorstandsvorsitzender | 01.01.2009 |
| Trafalgar Ventures, Inc. | Präsident | 12.10.2004 |
| HAEMONETICS CORPORATION | Corporate Officer/Principal | 01.01.2003 |
Genzyme Tissue Repair
 Genzyme Tissue Repair BiotechnologyHealth Technology Genzyme Tissue Repair develops biological products and devices for orthopedic injuries such as cartilage damage and severe burns. The company is headquartered in Cambridge, MA | Präsident | 01.01.1999 |
Ausbildung von Timothy R. Surgenor
| Williams College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HAEMONETICS CORPORATION | Health Technology |
| NEUROMETRIX, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
| Trafalgar Ventures, Inc. | Finance |
BioSurface Technology, Inc.
 BioSurface Technology, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, BioSurface Technology, Inc. is a commercial biotechnical research company. The company is based in Cambridge, MA. The company was founded by David L. Castaldi, Ben R. Bronstein. BioSurface Technology was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on December 16, 1994. | Commercial Services |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Health Technology |
Genzyme Tissue Repair
Genzyme Tissue Repair BiotechnologyHealth Technology Genzyme Tissue Repair develops biological products and devices for orthopedic injuries such as cartilage damage and severe burns. The company is headquartered in Cambridge, MA | Health Technology |
| Red Sky Partners LLC | |
Precision Ventures LLC (Massachusetts)
 Precision Ventures LLC (Massachusetts) Medical DistributorsDistribution Services Precision Ventures LLC develops and licenses defined collections of medical and consumer products. The company is headquartered in Waltham, MA. | Distribution Services |